Description: Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. Jinghua Pharmaceutical Group Co., Ltd. was founded in 1957 and is based in Nantong, China.
Home Page: www.jinghuapharm.com
No 2-02#, Xrd Between 3 Haibin Rd & 2 To
Nantong,
226407
China
Phone:
86 513 8560 9405
Officers
| Name | Title |
|---|---|
| Mr. Yunzhong Zhou | GM & Vice Chairman |
| Mr. Yuxiang Wu | Exec. Deputy GM, CFO & Director |
| Mr. Jianfeng Wang | Board Sec. |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 47.72 |
| Price-to-Book MRQ: | 5.1444 |
| Price-to-Sales TTM: | 8.3298 |
| IPO Date: | 2010-02-03 |
| Fiscal Year End: | December |
| Full Time Employees: | 1835 |